Aphios Pharma

Growth Stage

Inspired by Nature, Enabled by Science


Raised to Date: Raised: $48,152

Total Commitments ($USD)



Start Date


Close Date


Min. Goal
Max. Goal
Min. Investment


Security Type

Equity - Common

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share


Pre-Money Valuation


Rolling Commitments ($USD)

Reporting Date


Days Remaining
% of Min. Goal
% of Max. Goal
Likelihood of Max
Avg. Daily Raise


Create a free account today to gain access to KingsCrowd analytics.
Year Founded



Healthcare & Pharmaceuticals

Tech Sector



Woburn, Massachusetts

Aphios Pharma LLC is exploring how to best leverage, develop, and commercialize cannabis-based drugs for Central Nervous System (CNS) and other disorders. To accomplish this, Aphios Pharma “...utilizes supercritical fluid technologies to improve drug discovery, manufacturing, and formulation in a sustainable, environmentally-friendly manner.” They manufacture pharmaceutical-grade pure natural cannabinoids that both follow cGMP guidelines of the FDA and are in compliance with the Drug Enforcement Agency (DEA). So far, their work has led to endeavors that are likely to advance the science of cannabinoid-based medicines -- as well as make significant contributions to science and medicine.
Create a free account today to gain access to KingsCrowd analytics.

Raise History

Offering Name Close Date Platform Valuation/Cap Total Raised Security Type Status Reg Type
Aphios Pharma 07/31/2022 Wefunder $71,000,000 $97,041 SAFE Funded RegCF
Aphios Pharma 01/31/2019 Netcapital $101,070,000 $48,152 Equity - Common Funded RegCF
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)


$12.42 /month
billed annually
Free portfolio tracking and KingsCrowd's quantitative ratings on all raises.
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings (excluding risk)
Advanced company search ( with ratings)
Markets page filters and historical industry data
Get Edge Annual

Edge Pro

$41.58 /month
billed annually
Full site access including KingsCrowd's qualitative analyst reports.
Plan Includes:
Everything in Edge, plus
Full access to detailed Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
Search and filter based on Analyst Reports
In-depth risk ratings for every raise
Get Edge Pro Annual
Already a member? Log in here.
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.

Create your first portfolio

Create your own startup investment portfolio on KingsCrowd.

Track all of your startup investments in one place using our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
Aphios Pharma on Netcapital
Platform: Netcapital
Security Type: Equity - Common
Valuation: $101,070,000
Price per Share: $1.00

Follow company

Follow Aphios Pharma on Netcapital

Buy Aphios Pharma's Deal Report

Warning: according to the close date for this deal, Aphios Pharma may no longer be accepting investments.

Aphios Pharma Deal Report

Get KingsCrowd’s comprehensive report on Aphios Pharma including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Aphios Pharma is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Aphios Pharma deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge Pro